TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bristol-Myers Squibb AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,806,648
|
3,434,702
|
3,057,747 |
| Financial expenses |
165
|
37,050
|
9,705 |
| Earnings before taxes |
190,256
|
0
|
202,432 |
| EBITDA |
191,165
|
4,560
|
216,672 |
| Total assets |
1,463,364
|
1,322,943
|
2,262,332 |
| Current assets |
1,450,816
|
1,308,724
|
2,241,490 |
| Current liabilities |
640,656
|
638,003
|
1,636,034 |
| Equity capital |
822,051
|
683,729
|
622,880 |
| - share capital |
6,500
|
6,500
|
6,500 |
| Employees (average) |
155
|
164
|
160 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.2%
|
51.7%
|
27.5% |
| Turnover per employee |
24,559
|
20,943
|
19,111 |
| Profit as a percentage of turnover |
5.0%
|
0%
|
6.6% |
| Return on assets (ROA) |
13.0%
|
2.8%
|
9.4% |
| Current ratio |
226.5%
|
205.1%
|
137.0% |
| Return on equity (ROE) |
23.1%
|
0%
|
32.5% |
| Change turnover |
371,946
|
376,955
|
488,007 |
| Change turnover % |
11%
|
12%
|
19% |
| Chg. No. of employees |
-9
|
4
|
7 |
| Chg. No. of employees % |
-5%
|
3%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.